Conditions: Heart Valve Diseases
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 58
Healthy volunteers: no

Brief summary:
The purpose of the investigation is to determine whether Atrovastatin as anti-inflammatory agent can be effective in preventing from atrial fibrillation incidence in patients whom undergone open cardiac surgery for their heart valve repair.

Detailed description:

Arms:
arm 1: Atorvastatin 40 mg once daily from 3 days before surgery up to five days after surgery arm 2: Placebo

Interventions: intervention 1: Atorvastatin
Intervention descriptions: intervention 1: None

Protocol document: